Profile
Joao Siffert served as President, Chief Executive Officer & Director at Design Therapeutics, Inc. from 2020 to 2023.
Prior to that, he was the Chief Executive & Medical Officer, Director at Abeona Therapeutics, Inc. from 2019 to 2020.
He also held positions as an Independent Director at Alcobra Ltd. and Arcturus Therapeutics, Inc. Additionally, he served as the Chief Scientific & Medical Officer at Pfizer Inc. and Avanir Pharmaceuticals, Inc. from 2011 to 2016.
He was also the Chief Medical & Scientific Officer at Avera Pharmaceuticals, Inc. from 2005 to 2007 and the Chief Medical Officer & Vice President at Ceregene, Inc. from 2007 to 2011.
He started his career as an Assistant Professor at Albert Einstein College of Medicine, Inc. and later became a Principal at Beth Israel Medical Center.
He earned an MBA from Columbia Business School and a doctorate from Universidade De Sao Paulo Faculdade De Medicina.
Former positions of Joao Siffert
| Companies | Position | End |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Chief Executive Officer | 25/08/2023 |
| ABEONA THERAPEUTICS INC. | Chief Executive Officer | 23/09/2020 |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Chief Tech/Sci/R&D Officer | 01/10/2018 |
| AVEXIS INC | Director/Board Member | 14/05/2018 |
| AVANIR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/04/2016 |
Training of Joao Siffert
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops drugs and therapies | Health Services |
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for neurodegenerative disorders | Health Technology |
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Beth Israel Medical Center
Beth Israel Medical Center Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Universidade De Sao Paulo Faculdade De Medicina
Universidade De Sao Paulo Faculdade De Medicina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Design Therapeutics, Inc.
Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
- Stock Market
- Insiders
- Joao Siffert
















